We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 9,072

FDA Holding its First Public Meeting on Drug Product Identification Requirements in October
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • September 27 2016

Last week FDA published a notice of public meeting and a request for comments regarding certain aspects of the Drug Supply Chain Security Act (DSCSA


Massachusetts Hospital Licensing Regulations Proposed Amendments - Key Take-Aways
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • September 26 2016

The Massachusetts Department of Public Health (DPH) has released for public comment proposed amendments to DPH’s Hospital Licensure Regulations (105


Can Employees Commute Tax-Free on Uber or Lyft?
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • September 26 2016

Uber, Lyft, and their competitors, offering handy apps, responsive drivers and competitive prices, are fast becoming a favored commuter option. Many


2018 Green Card Lottery Registration
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • September 23 2016

On October 1, 2016, the US Department of State will begin accepting requests to register for the 2018 Diversity Immigrant Visa Program (DV-2018), also


Addressing Zika’s Continued Threat to the Workplace
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • September 22 2016

The growing prevalence of the Zika virus in the United States has already presented a number of hurdles for employers striving to create a safe and


EB-5 Will Likely Be Extended as Part of Continuing Resolution Through December 9, 2016
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • September 22 2016

This afternoon, a draft of the Continuing Resolution (CR) began circulating in Washington, DC. The CR, which Congress will likely pass early next week


Administration’s Biotechnology Working Group Updates Coordinated Framework & Unveils National Strategy
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • September 21 2016

After launching with an ambitious agenda fourteen months ago (as we wrote about here), last Friday the Obama Administration announced that its


Penalties For Health Care Law Violations Surge
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • September 21 2016

The civil monetary penalties for violations of myriad health care laws continue to rise. In June, we discussed the enormous increase in penalties


Apotex to Supreme Court: Review BPCIA 180-Day Notice Requirement
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • September 21 2016

On September 9, 2016, Apotex Inc. filed a petition for writ of certiorari in the U.S. Supreme Court seeking review of the Federal Circuit’s decision


Louisiana Supreme Court Adopts Pro Rata Allocation of Defense Costs among Insurers and Insured
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • September 20 2016

On September 7, 2016, the Louisiana Supreme Court applied, for the first time, a pro rata allocation method to defense costs where commercial general